Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Expert Opinion on Therapeutic Patents
|
May 20, 2026
An update on PDGFR inhibitors: a patent review (2020 - present)
Sisir Nandi, Sarfaraz Ahmed, Soubhik Barma, et al.
Current Medicinal Chemistry
|
May 22, 2023
To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds
Banani Bhattacharjee, Arnob Chakrovorty, Maharaj Biswas, et al.
Current Drug Discovery Technologies
|
January 27, 2026
Cyclic Peptides in Wound Hydrogels: Current Advances and Future Directions
Shahjad, Yashika Garg, Arun Kumar, et al.
Combinatorial Chemistry & High Throughput Screening
|
December 31, 2020
A Quality by Design Approach of Metronidazole Bigel and Assessment of Antimicrobial Study Utilizing Box-behnken Design
Harekrishna Roy, Sudhir Maddela, Alekhya Munagala, et al.
Combinatorial Chemistry & High Throughput Screening
|
September 17, 2021
Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes
Rishita Dey, Sudatta Dey, Asmita Samadder, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 10, 2021
Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography
Sisir Nandi, Rishita Dey, Sudatta Dey, et al.
Current Medicinal Chemistry
|
March 3, 2021
Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents
Sisir Nandi, Rishita Dey, Asmita Samadder, et al.
Current Topics in Medicinal Chemistry
|
December 1, 2022
Repurposing of Chemotherapeutics to Combat COVID-19
Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede, et al.
Current Topics in Medicinal Chemistry
|
September 5, 2020
Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against <i>M. tuberculosis</i> Enzyme Targets
Rishita Dey, Sisir Nandi, Asmita Samadder, et al.
Cancer Treatment and Research
|
May 17, 2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches
Bhabani Shankar Nayak, Bangmayee Dash, Sisir Nandi, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Expert Opinion on Therapeutic Patents
|
May 20, 2026
An update on PDGFR inhibitors: a patent review (2020 - present)
Sisir Nandi, Sarfaraz Ahmed, Soubhik Barma, et al.
Current Medicinal Chemistry
|
May 22, 2023
To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds
Banani Bhattacharjee, Arnob Chakrovorty, Maharaj Biswas, et al.
Current Drug Discovery Technologies
|
January 27, 2026
Cyclic Peptides in Wound Hydrogels: Current Advances and Future Directions
Shahjad, Yashika Garg, Arun Kumar, et al.
Combinatorial Chemistry & High Throughput Screening
|
December 31, 2020
A Quality by Design Approach of Metronidazole Bigel and Assessment of Antimicrobial Study Utilizing Box-behnken Design
Harekrishna Roy, Sudhir Maddela, Alekhya Munagala, et al.
Combinatorial Chemistry & High Throughput Screening
|
September 17, 2021
Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes
Rishita Dey, Sudatta Dey, Asmita Samadder, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 10, 2021
Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography
Sisir Nandi, Rishita Dey, Sudatta Dey, et al.
Current Medicinal Chemistry
|
March 3, 2021
Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents
Sisir Nandi, Rishita Dey, Asmita Samadder, et al.
Current Topics in Medicinal Chemistry
|
December 1, 2022
Repurposing of Chemotherapeutics to Combat COVID-19
Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede, et al.
Current Topics in Medicinal Chemistry
|
September 5, 2020
Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against <i>M. tuberculosis</i> Enzyme Targets
Rishita Dey, Sisir Nandi, Asmita Samadder, et al.
Cancer Treatment and Research
|
May 17, 2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches
Bhabani Shankar Nayak, Bangmayee Dash, Sisir Nandi, et al.
Page
of 7